Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors

T. Jake Liang, Andrea E. Reid, Ramnik Xavier, Robert Cardiff, Timothy C. Wang

Research output: Contribution to journalArticle

80 Scopus citations

Abstract

Receptor tyrosine kinases are important in cell signal transduction and proliferation. Abnormal expression of tyrosine kinases often leads to malignant transformation. C-met is a tyrosine kinase receptor and its ligand is hepatocyte growth factor (HGF). HGF/c-met plays diverse roles in regulation of cell growth, shape and movement. Constitutively activated met, such as tpr-met, is a potent oncogene in vitro, but its carcinogenic role in vivo remains unclear. Our study demonstrates that expression of tpr-met leads to development of mammary tumors and other malignancies in transgenic mice, and suggests that deregulated met expression may be involved in mammary carcinogenesis.

Original languageEnglish (US)
Pages (from-to)2872-2877
Number of pages6
JournalJournal of Clinical Investigation
Volume97
Issue number12
DOIs
StatePublished - Jun 15 1996

Keywords

  • c-met
  • carcinogenesis
  • hepatocyte growth factor
  • receptor tyrosine kinase
  • sarcoma

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors'. Together they form a unique fingerprint.

  • Cite this